dc.creatorAvaria, María de los Ángeles
dc.creatorBeytía, María de los Ángeles
dc.creatorKleinsteuber, Karin
dc.creatorRodillo, Eliana
dc.creatorAlegría, Sylvia
dc.date.accessioned2019-03-11T13:19:29Z
dc.date.available2019-03-11T13:19:29Z
dc.date.created2019-03-11T13:19:29Z
dc.date.issued2012
dc.identifierRevista Chilena de Pediatria, Volumen 83, Issue 3, 2018, Pages 258-261
dc.identifier03704106
dc.identifier07176228
dc.identifier10.4067/S0370-41062012000300007
dc.identifierhttps://repositorio.uchile.cl/handle/2250/165627
dc.description.abstractCommonly used in clinical practice, glutamic oxalacetic (GOT) and glutamic piruvic (GPT) transaminases are produced in various body tissues, including striated muscle, so their blood elevation is not due exclusively to liver disease. The objective of this study is to demonstrate the correlation between elevated creatinkinase (CK) and transaminases in patients with diagnosis of Duchenne muscular dystrophy (DMD), the most frequent neuromuscular disease in children. Patients and Method: Assessment in 61 children with diagnosis of DMD of CK, AST and ALT levels, and their correlation. Results: All patients had increase of CK (x̄ = 13.363 IU/L), AST (x̄ = 203 IU/L) and ALT (x̄ = 194 IU/L) above normal values. The increase of transaminases related directly with the increase of CK. Conclusion: Patients with DMD have increased transaminases, so it is necessary to include this diagnostic possibility in a child with hypertransaminemia, prior to performing liver biopsy.
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceRevista Chilena de Pediatria
dc.subjectCreatinkinase
dc.subjectDuchenne
dc.subjectMuscular dystrophy
dc.subjectTransaminases
dc.titleTransaminases increase: A manifestation of Duchenne's muscular dystrophy Aumento de transaminasas: Una manifestación de distrofia muscular de Duchenne
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución